Interleukin	0	11	B-Gene_or_gene_product
-	11	12	I-Gene_or_gene_product
1	12	13	I-Gene_or_gene_product
receptor	14	22	I-Gene_or_gene_product
antagonist	23	33	I-Gene_or_gene_product
inhibits	34	42	O
ischaemic	43	52	O
and	53	56	O
excitotoxic	57	68	O
neuronal	69	77	B-Cell
damage	78	84	O
in	85	87	O
the	88	91	O
rat	92	95	B-Organism
.	95	96	O

Interleukin	98	109	B-Gene_or_gene_product
-	109	110	I-Gene_or_gene_product
1	110	111	I-Gene_or_gene_product
(	112	113	O
IL	113	115	B-Gene_or_gene_product
-	115	116	I-Gene_or_gene_product
1	116	117	I-Gene_or_gene_product
)	117	118	O
synthesis	119	128	O
in	129	131	O
the	132	135	O
brain	136	141	B-Organ
is	142	144	O
stimulated	145	155	O
by	156	158	O
mechanical	159	169	O
injury	170	176	O
and	177	180	O
IL	181	183	B-Gene_or_gene_product
-	183	184	I-Gene_or_gene_product
1	184	185	I-Gene_or_gene_product
mimics	186	192	O
some	193	197	O
effects	198	205	O
of	206	208	O
injury	209	215	O
,	215	216	O
such	217	221	O
as	222	224	O
gliosis	225	232	O
and	233	236	O
neovascularization	237	255	O
.	255	256	O

We	257	259	O
report	260	266	O
that	267	271	O
neuronal	272	280	B-Cell
death	281	286	O
resulting	287	296	O
from	297	301	O
focal	302	307	O
cerebral	308	316	O
ischaemia	317	326	O
(	327	328	O
middle	328	334	O
cerebral	335	343	B-Multi-tissue_structure
artery	344	350	I-Multi-tissue_structure
occlusion	351	360	O
,	360	361	O
24	362	364	O
h	365	366	O
)	366	367	O
is	368	370	O
significantly	371	384	O
inhibited	385	394	O
(	395	396	O
by	396	398	O
50	399	401	O
%	401	402	O
)	402	403	O
in	404	406	O
rats	407	411	B-Organism
injected	412	420	O
with	421	425	O
a	426	427	O
recombinant	428	439	O
IL	440	442	B-Gene_or_gene_product
-	442	443	I-Gene_or_gene_product
1	443	444	I-Gene_or_gene_product
receptor	445	453	I-Gene_or_gene_product
antagonist	454	464	I-Gene_or_gene_product
(	465	466	O
IL	466	468	B-Gene_or_gene_product
-	468	469	I-Gene_or_gene_product
1ra	469	472	I-Gene_or_gene_product
,	472	473	O
10	474	476	O
micrograms	477	487	O
,	487	488	O
icv	489	492	O
30	493	495	O
min	496	499	O
before	500	506	O
and	507	510	O
10	511	513	O
min	514	517	O
after	518	523	O
ischaemia	524	533	O
)	533	534	O
.	534	535	O

Excitotoxic	536	547	O
damage	548	554	O
due	555	558	O
to	559	561	O
striatal	562	570	O
infusion	571	579	O
of	580	582	O
an	583	585	O
NMDA	586	590	B-Drug_or_compound
-	590	591	O
receptor	591	599	O
agonist	600	607	O
(	608	609	O
cis	609	612	B-Drug_or_compound
-	612	613	I-Drug_or_compound
2	613	614	I-Drug_or_compound
,	614	615	I-Drug_or_compound
4	615	616	I-Drug_or_compound
-	616	617	I-Drug_or_compound
methanoglutamate	617	633	I-Drug_or_compound
)	633	634	O
was	635	638	O
also	639	643	O
markedly	644	652	O
inhibited	653	662	O
(	663	664	O
71	664	666	O
%	666	667	O
)	667	668	O
by	669	671	O
injection	672	681	O
of	682	684	O
the	685	688	O
IL	689	691	B-Gene_or_gene_product
-	691	692	I-Gene_or_gene_product
1ra	692	695	I-Gene_or_gene_product
.	695	696	O

These	697	702	O
data	703	707	O
indicate	708	716	O
that	717	721	O
endogenous	722	732	O
IL	733	735	B-Gene_or_gene_product
-	735	736	I-Gene_or_gene_product
1	736	737	I-Gene_or_gene_product
is	738	740	O
a	741	742	O
mediator	743	751	O
of	752	754	O
ischaemic	755	764	O
and	765	768	O
excitotoxic	769	780	O
brain	781	786	B-Organ
damage	787	793	O
,	793	794	O
and	795	798	O
that	799	803	O
inhibitors	804	814	O
of	815	817	O
IL	818	820	B-Gene_or_gene_product
-	820	821	I-Gene_or_gene_product
1	821	822	I-Gene_or_gene_product
action	823	829	O
may	830	833	O
be	834	836	O
of	837	839	O
therapeutic	840	851	O
value	852	857	O
in	858	860	O
the	861	864	O
treatment	865	874	O
of	875	877	O
acute	878	883	O
or	884	886	O
chronic	887	894	O
neuronal	895	903	B-Cell
death	904	909	O
.	909	910	O

